Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 4Recruiting 2Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2Lymphoid 1CNS 1

Conditions

Motor Activity 2Esophageal Neoplasms 2Stomach Neoplasms 1Gastrointestinal Neoplasms 1Disease 1Adenocarcinoma Of Esophagus 1

Interventions

Oxaliplatin 197Bevacizumab 162Fluorouracil 155Capecitabine 137Gemcitabine 133Leucovorin 112pembrolizumab 99Cisplatin 93Drug Therapy 89Irinotecan 81Radiotherapy 73sintilimab 70durvalumab 65130-nm albumin-bound paclitaxel 65Paclitaxel 64Specimen Handling 62Cetuximab 61lenvatinib 59tislelizumab 58Nivolumab 55Magnetic Resonance Spectroscopy 55Folfox protocol 55Blood Specimen Collection 52atezolizumab 48Biopsy 46Surgical Procedures, Operative 40Taxes 38Albumin-Bound Paclitaxel 38Immune Checkpoint Inhibitors 37HMPL-013 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × High-Intensity Interval Training × Gastrointestinal × Clear all
NCT07561840 2026-05-19

Exercise Training After Upper Gastrointestinal Cancer Surgery

Kansai Medical University

Phase NA Recruiting
171 enrolled
Gastrointestinal

Disease, Esophageal Neoplasms, Gastrointestinal Neoplasms, Motor Activity, Stomach Neoplasms

NCT07375420 2026-02-02

OPTIMUS

University of Surrey

Phase NA Recruiting
50 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡